— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
P/E
—
P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
−72.1%
−73.6%
no band (48 mo · 4 distinct)
—
—
−36.9%
48 · 4
−209.6% (2024-08)
—
no band (12 mo · 1 distinct)
—
—
−15.4%
12 · 1
−165.1%
−192.2%
90th
+0.65σ
−21.3%
60 · 5
−42.2%
−72.4%
no band (48 mo · 48 distinct)
—
—
5.1%
48 · 48
EPS Growth 3Y
—
P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
65.5%
—
no band (24 mo · 2 distinct)
—
—
9.0%
24 · 2
Market Cap
$5.27M
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
ROE (point-in-time)Health Care median, same monthshaded = own p10–p90 · dashed = own median · right-edge tick = today
shown for reference only — the reconstructed distribution did not clear the band gate, so no rank is quoted.
Multiple-implied price ladder · Full
Filed earnings only.
no P/E ladder — P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
Ladder not drawn for this name — the reason is above.ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
INM is not drawn here: its newest pool year (CY2024) differs from the industry’s (CY2025), so its 0.0% is a different year’s share.
Growth, restated as sharewhere each pace has to END UP, by 2029
Its own realised pace0.0% → 0.0%
The pace the price requires— The growth today's price requires (our reverse-DCF) is a Pro metric — the realized-pace runway above is free.
INM share over time5 published years
Calendar year
2020
2021
2022
2023
2024
Share of covered pool
0.0%
0.0%
0.0%
0.0%
0.0%
year: this company's newest published… · share_5y: this company has no 2019… · coverage: 346 of the 377 members that…
Share of covered industry revenue · n=385 in Pharmaceuticals & Biotechnology · CY2024 pool · built 2026-08-20 not market shareⓘ
Covered filers only, not market share — private and uncovered companies are missing, so every share here reads high. Years are FX-converted and published only once most of the pool has filed.
